Cyclic Ruthenium-Peptide Prodrugs Penetrate the Blood–Brain Barrier and Attack Glioblastoma upon Light Activation in Orthotopic Zebrafish Tumor Models

Liyan Zhang, Gangyin Zhao, Trevor Dalrymple, Yurii Husiev, Hildert Bronkhorst, Gabriel Forn-Cuní, Bruno Lopes-Bastos, Ewa Snaar-Jagalska, Sylvestre Bonnet · 2024

Read Cyclic Ruthenium-Peptide Prodrugs Penetrate the Blood–Brain Barrier and Attack Glioblastoma upon Light Activation in Orthotopic Zebrafish Tumor Models by Liyan Zhang, Gangyin Zhao, Trevor Dalrymple, Yurii Husiev, Hildert Bronkhorst, Gabriel Forn-Cuní, Bruno Lopes-Bastos, Ewa Snaar-Jagalska, Sylvestre Bonnet (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11672551.txt.

Description

Brain tumors are hard to drug because the blood-brain barrier turns most medicines away. Liyan Zhang led a team testing light-activated drugs that ride a targeting peptide across that barrier. Three versions join a ruthenium warhead, a metal center that turns toxic under light, to a ring-shaped peptide that homes to tumor vessels. Small changes in the ring's links switch how the drug kills.

One version works without oxygen, a plus inside starved tumors; another leans on oxygen like classic light therapy. All three crossed the barrier in zebrafish carrying human brain tumors and hit the tumors well. In dishes they killed tumor balls with matching strength. The team presents them as flexible candidates for a stubborn cancer.

Catalog record

CREATORLiyan Zhang, Gangyin Zhao, Trevor Dalrymple, Yurii Husiev, Hildert Bronkhorst, Gabriel Forn-Cuní, Bruno Lopes-Bastos, Ewa Snaar-Jagalska, Sylvestre Bonnet
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE78 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11672551

Browse the full library · About the Tower of Babel